{"DataElement":{"publicId":"6038818","version":"2","preferredName":"Leukemia Cytogenetics Status","preferredDefinition":"The indication of the occurrence of an indicated high-risk prognostic cytogenetic abnormality.","longName":"LEUK_CYTOGEN_STAT","context":"COG","contextVersion":"1","DataElementConcept":{"publicId":"6038815","version":"1","preferredName":"Cytogenetics Status Leukemia","preferredDefinition":"Cytogenetics is the study of chromosomes and the related disease states caused by numerical and structural chromosome abnormalities._A condition or state at a particular time._A malignant (clonal) hematologic disorder, involving hematopoietic stem cells and characterized by the presence of primitive or atypical myeloid or lymphoid cells in the bone marrow and the blood. Leukemias are classified as acute or chronic based on the degree of cellular differentiation and the predominant cell type present. Leukemia is usually associated with anemia, fever, hemorrhagic episodes, and splenomegaly. Common leukemias include acute myeloid leukemia, chronic myelogenous leukemia, acute lymphoblastic or precursor lymphoblastic leukemia, and chronic lymphocytic leukemia. Treatment is vital to patient survival; untreated, the natural course of acute leukemias is normally measured in weeks or months, while that of chronic leukemias is more often measured in months or years.","longName":"Leuk_Cytogen_Stat","context":"COG","contextVersion":"1","ObjectClass":{"publicId":"6038813","version":"1","preferredName":"Leukemia Cytogenetics","preferredDefinition":"A malignant (clonal) hematologic disorder, involving hematopoietic stem cells and characterized by the presence of primitive or atypical myeloid or lymphoid cells in the bone marrow and the blood. Leukemias are classified as acute or chronic based on the degree of cellular differentiation and the predominant cell type present. Leukemia is usually associated with anemia, fever, hemorrhagic episodes, and splenomegaly. Common leukemias include acute myeloid leukemia, chronic myelogenous leukemia, acute lymphoblastic or precursor lymphoblastic leukemia, and chronic lymphocytic leukemia. Treatment is vital to patient survival; untreated, the natural course of acute leukemias is normally measured in weeks or months, while that of chronic leukemias is more often measured in months or years.:The branch of biology that studies the cellular aspects of heredity, especially the chromosomes. Includes the study of disease states caused by numerical and structural chromosome abnormalities.","longName":"C3161:C16487","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Leukemia","conceptCode":"C3161","definition":"A malignant (clonal) hematologic disorder, involving hematopoietic stem cells and characterized by the presence of primitive or atypical myeloid or lymphoid cells in the bone marrow and the blood. Leukemias are classified as acute or chronic based on the degree of cellular differentiation and the predominant cell type present. Leukemia is usually associated with anemia, fever, hemorrhagic episodes, and splenomegaly. Common leukemias include acute myeloid leukemia, chronic myelogenous leukemia, acute lymphoblastic or precursor lymphoblastic leukemia, and chronic lymphocytic leukemia. Treatment is vital to patient survival; untreated, the natural course of acute leukemias is normally measured in weeks or months, while that of chronic leukemias is more often measured in months or years.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Cytogenetics","conceptCode":"C16487","definition":"The branch of biology that studies the cellular aspects of heredity, especially the chromosomes. Includes the study of disease states caused by numerical and structural chromosome abnormalities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5FB4DD67-1115-617F-E053-F662850A2B8E","latestVersionIndicator":"Yes","beginDate":"2017-12-06","endDate":null,"createdBy":"ROSSD","dateCreated":"2017-12-06","modifiedBy":"ONEDATA","dateModified":"2017-12-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2320064","version":"1","preferredName":"Status","preferredDefinition":"A condition or state at a particular time.","longName":"C25688","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Status","conceptCode":"C25688","definition":"A condition or state at a particular time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"FC71B93E-037B-5AD9-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-07-25","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-07-25","modifiedBy":"ONEDATA","dateModified":"2005-07-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2435022","version":"1","preferredName":"Disease, Disorder or Finding","preferredDefinition":"Specification of human conditions relevant to cancer. This includes observations, test results, history, and other concepts relevant to characterization of human cancer-related conditions. Non-neoplastic conditions of interest are also included.","longName":"C7057","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87D9-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"COG CRF:Children's Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5FB4DD67-1123-617F-E053-F662850A2B8E","latestVersionIndicator":"Yes","beginDate":"2017-12-06","endDate":null,"createdBy":"ROSSD","dateCreated":"2017-12-06","modifiedBy":"MAESKEB","dateModified":"2019-04-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"6038817","version":"1.1","preferredName":"Leukemia Cytogenetics Status","preferredDefinition":"The value domain indicating the occurrence or incidence of Leukemia Cytogenetics Status.","longName":"LEUK_CYTOGEN_STAT","context":"COG","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"15","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Not Available","valueDescription":"Not Available","ValueMeaning":{"publicId":"2562605","version":"1","preferredName":"Not Available","longName":"2562605","preferredDefinition":"Information regarding the subject is unknown or inaccessible at this time.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"No Information Available","conceptCode":"C53269","definition":"Information regarding the subject is unknown or inaccessible at this time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-C19A-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-04-02","endDate":null,"createdBy":"SBREXT","dateCreated":"2002-10-11","modifiedBy":"COOPERM","dateModified":"2012-10-31","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"86201759-586A-1E1C-E053-F662850A352F","beginDate":"2017-12-06","endDate":null,"createdBy":"SETRAKIN","dateCreated":"2019-04-09","modifiedBy":"ONEDATA","dateModified":"2019-04-09","deletedIndicator":"No"},{"value":"Not Done","valueDescription":"Not Done","ValueMeaning":{"publicId":"2568055","version":"1","preferredName":"Not Done","longName":"2568055","preferredDefinition":"Indicates a task, process or examination that has either not been initiated or not been completed.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Not Done","conceptCode":"C49484","definition":"Indicates a task, process or examination that has either not been initiated or not been completed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D6E4-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-01-12","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-01-12","modifiedBy":"REEVESD","dateModified":"2014-04-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"86201759-5874-1E1C-E053-F662850A352F","beginDate":"2017-12-06","endDate":null,"createdBy":"SETRAKIN","dateCreated":"2019-04-09","modifiedBy":"ONEDATA","dateModified":"2019-04-09","deletedIndicator":"No"},{"value":"No","valueDescription":"No","ValueMeaning":{"publicId":"2559515","version":"1","preferredName":"No","longName":"2559515","preferredDefinition":"The non-affirmative response to a question.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"No","conceptCode":"C49487","definition":"The non-affirmative response to a question.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B588-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"GDEEN","dateModified":"2024-01-02","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"86201759-587E-1E1C-E053-F662850A352F","beginDate":"2017-12-06","endDate":null,"createdBy":"SETRAKIN","dateCreated":"2019-04-09","modifiedBy":"ONEDATA","dateModified":"2019-04-09","deletedIndicator":"No"},{"value":"Yes","valueDescription":"Yes","ValueMeaning":{"publicId":"2567168","version":"1","preferredName":"Yes","longName":"2567168","preferredDefinition":"The affirmative response to a question.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Yes","conceptCode":"C49488","definition":"The affirmative response to a question.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D36D-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-11-13","endDate":null,"createdBy":"SBREXT","dateCreated":"2003-11-13","modifiedBy":"GDEEN","dateModified":"2024-01-02","changeDescription":"12/29/2006 - Updated with NCI Thesaurus definition.","administrativeNotes":"2022.12.29 Alt VM added per ticket request CADSR0001837. ak","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"86201759-5888-1E1C-E053-F662850A352F","beginDate":"2017-12-06","endDate":null,"createdBy":"SETRAKIN","dateCreated":"2019-04-09","modifiedBy":"ONEDATA","dateModified":"2019-04-09","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008557","version":"1","preferredName":"Lab Results","preferredDefinition":"the results of laboratory tests.","longName":"LAB_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2CFBA7D-D009-7227-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"6038816","version":"1","preferredName":"Leukemia Cytogenetics Status","preferredDefinition":"A malignant (clonal) hematologic disorder, involving hematopoietic stem cells and characterized by the presence of primitive or atypical myeloid or lymphoid cells in the bone marrow and the blood. Leukemias are classified as acute or chronic based on the degree of cellular differentiation and the predominant cell type present. Leukemia is usually associated with anemia, fever, hemorrhagic episodes, and splenomegaly. Common leukemias include acute myeloid leukemia, chronic myelogenous leukemia, acute lymphoblastic or precursor lymphoblastic leukemia, and chronic lymphocytic leukemia. Treatment is vital to patient survival; untreated, the natural course of acute leukemias is normally measured in weeks or months, while that of chronic leukemias is more often measured in months or years.:The branch of biology that studies the cellular aspects of heredity, especially the chromosomes. Includes the study of disease states caused by numerical and structural chromosome abnormalities.:A condition or state at a particular time.","longName":"C3161:C16487:C25688","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Leukemia","conceptCode":"C3161","definition":"A malignant (clonal) hematologic disorder, involving hematopoietic stem cells and characterized by the presence of primitive or atypical myeloid or lymphoid cells in the bone marrow and the blood. Leukemias are classified as acute or chronic based on the degree of cellular differentiation and the predominant cell type present. Leukemia is usually associated with anemia, fever, hemorrhagic episodes, and splenomegaly. Common leukemias include acute myeloid leukemia, chronic myelogenous leukemia, acute lymphoblastic or precursor lymphoblastic leukemia, and chronic lymphocytic leukemia. Treatment is vital to patient survival; untreated, the natural course of acute leukemias is normally measured in weeks or months, while that of chronic leukemias is more often measured in months or years.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Cytogenetics","conceptCode":"C16487","definition":"The branch of biology that studies the cellular aspects of heredity, especially the chromosomes. Includes the study of disease states caused by numerical and structural chromosome abnormalities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Status","conceptCode":"C25688","definition":"A condition or state at a particular time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5FB4F9AA-B759-024D-E053-F662850A9312","latestVersionIndicator":"Yes","beginDate":"2017-12-06","endDate":null,"createdBy":"ROSSD","dateCreated":"2017-12-06","modifiedBy":"ONEDATA","dateModified":"2017-12-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"COG CRF:Children's Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"86201759-5854-1E1C-E053-F662850A352F","latestVersionIndicator":"Yes","beginDate":"2017-12-06","endDate":null,"createdBy":"SETRAKIN","dateCreated":"2019-04-09","modifiedBy":"MAESKEB","dateModified":"2019-04-10","changeDescription":"Workflow and Registration Status Changed per Brenda Duggan; 05.16.18 Versioned VD added max VD length and edited short name 4/9/19 NS","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2961451","version":"1","longName":"Children's Oncology Group (COG)","context":"COG","ClassificationSchemeItems":[{"publicId":"2961452","version":"1","longName":"Statistics and Data Center","context":"COG"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Leukemia Cytogenetics Status","type":"Preferred Question Text","description":"Leukemia Cytogenetics Status","url":null,"context":"COG"},{"name":"Philadelphia Chromosome","type":"Alternate Question Text","description":"Philadelphia Chromosome","url":null,"context":"COG"},{"name":"MLL Rearrangement","type":"Alternate Question Text","description":"MLL Rearrangement","url":null,"context":"COG"},{"name":"ETV6 / RUNX1","type":"Alternate Question Text","description":"ETV6 / RUNX1","url":null,"context":"COG"},{"name":"iAMP21","type":"Alternate Question Text","description":"iAMP21","url":null,"context":"COG"},{"name":"Hypodiploidy","type":"Alternate Question Text","description":"Hypodiploidy","url":null,"context":"COG"},{"name":"Ph-like disease","type":"Alternate Question Text","description":"Ph-like disease","url":null,"context":"COG"},{"name":"COG CRF Text 1","type":"Alternate Question Text","description":"iAMP21:","url":null,"context":"COG"}],"origin":"COG CRF:Children's Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"861FA476-9E37-5DC2-E053-F662850AB7C7","latestVersionIndicator":"Yes","beginDate":"2017-12-06","endDate":null,"createdBy":"SETRAKIN","dateCreated":"2019-04-09","modifiedBy":"MAESKEB","dateModified":"2019-04-10","changeDescription":"Workflow and Registration Status Changed per Brenda Duggan; 05.16.18 Versioned CDE, updated VD and versioned 4/9/19 NS","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}